Dow Up 1.31% Nasdaq Up 2.40%

TrovaGene, Inc. (TROV)

-NasdaqCM
4.45 Up 0.02(0.45%) 4:00PM EDT
Prev Close:4.43
Open:4.52
Bid:4.43 x 100
Ask:4.45 x 200
1y Target Est:9.00
Beta:0.75
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.41 - 4.66
52wk Range:2.97 - 7.56
Volume:34,229
Avg Vol (3m):165,102
Market Cap:84.11M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TROV

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):324.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback